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Mitochondria in a variety of cell types respond to physiological Ca2+ oscillations in the cytosol dynamically with Ca2+ uptakes. In heart cells,
mitochondrial Ca2+ uptakes occur by a ruthenium red-sensitive Ca2+ uniporter (CaUP), a rapid mode of Ca2+ uptake (RaM) and a ryanodine
receptor (RyR) localized in the inner mitochondrial membrane (IMM). Three subtypes of RyRs have been described and cloned, however, the
subtype identity of the mitochondrial ryanodine receptor (mRyR) is unknown. Using subtype specific antibodies, we characterized the mRyR in
the IMM from rat heart as RyR1. These results are substantiated by the absence of RyR protein in heart mitochondria from RyR1 knockout mice.
The bell-shape Ca2+-dependent [3H]ryanodine binding curve and its modulation by caffeine and adenylylmethylenediphosphonate (AMPPCP)
give further evidence that mRyR functions pharmacologically like RyR1. Ryanodine prevents mitochondrial Ca2+ uptake induced by raising
extramitochondrial Ca2+ to 10 AM. Similarly, ryanodine inhibits oxidative phosphorylation stimulated by 10 AM extramitochondrial Ca2+. In
summary, our results show that the mRyR in cardiac muscle has similar biochemical and pharmacological properties to the RyR1 in the
sarcoplasmic reticulum (SR) of skeletal muscle. These results could also suggest an efficient mechanism by which mitochondria sequesters Ca2+
via mRyR during excitation–contraction coupling to stimulate oxidative phosphorylation for ATP production to meet metabolic demands. Thus,
the mRyR functions as a transducer for excitation–metabolism coupling.
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tion of these Ca2+-regulated processes has been implicated in
the development of diseases such as cardiomyopathy [5],
diabetes [6], and neurodegeneration [7]. Consequently, mito-
chondrial Ca2+ uptake mechanisms, generally named as Ca2+
uniporters (CaUP), have been studied extensively (for review
see [8]).
Although recent advances of patch-clamp techniques have
contributed to the pharmacological and biophysical charac-
terization of Ca2+ activated channels in the IMM [9–11],
these efforts have yielded little information regarding the
molecular identity of these mitochondrial Ca2+ transport
mechanisms. Presently, the only known molecular identity
of a mitochondrial Ca2+ transporter is our recent discovery of
a mRyR in the IMM of rat heart, which mediates a fast,cta 1717 (2005) 1 – 10
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Table 1
Primers used for RyR subtype-specific RNA amplification
Protein Primer sequence Base
pairs
Reference
RyR1 5V-GGTGGCCTTCAACTTCTTC-3V
(forward)
293 [55]
5V-ACTTGCTCTTGTTGGTCTCCG-3V
(reverse)
RyR2 5V-GAATCAGTCAGTTACTGGGCATGG-3V
(forward)
635 [31]
5V-CTGGTCTCTGAGTTCTCCAAAAGC-3V
(reverse)
RyR3 5V-AGAAGAGCCCAAAGCAGAGG-3V
(forward)
505 [30]
5V-GGAGGVVAACGGTCAGA-3V
(reverse)
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estingly, the pharmacological characteristics of the mRyR,
such as a bell-shaped Ca2+ dependency of [3H]ryanodine
binding, the inhibition of [3H]ryanodine binding in the
presence of Mg2+ (IC50=0.29 mM), ruthenium red (RR,
IC50=74 nM), and dantrolene, are reminiscent of the skeletal
muscle RyR in the sarcoplasmic reticulum (SR), RyR1 [12–
15]. Another intriguing property of the mRyR is its ability for
fast Ca2+ transport. In response to extramitochondrial Ca2+
pulses, Ca2+ uptake by the mRyR peaks within the shortest
sampling interval of one image frame that was used (250 ms,
[12]). This observed fast Ca2+ uptake kinetics is similar to
that of mitochondrial ATP production in response to extra-
mitochondrial Ca2+ pulses, which occur within 150 ms [16].
Therefore, an attractive hypothesis is that the mRyR serves as
a conduit between extramitochondrial Ca2+ pulses and
intramitochondrial ATP generation.
The aims of this study are to test the hypothesis that (1) the
mRyR is comprised of the type 1 RyR isoform, and (2) the
mRyR is an important mitochondrial Ca2+ uptake mechanism
for Ca2+ stimulated oxygen (O2) consumption. Using immu-
nological, pharmacological, and physiological methods, we
show here that the cardiac mRyR behaves like the skeletal
muscle RyR1. In addition, Ca2+ uptake through the mRyR
activates mitochondrial O2 consumption, indicative for mito-
chondrial ATP generation. These results suggest that, in
addition to the well-described role of releasing Ca2+ from the
SR of skeletal muscle for generating contraction, RyR1
channels serve as a critical Ca2+ uptake mechanism in cardiac
mitochondria for increasing ATP production.
2. Methods
2.1. Material
Ryanodine was purchased from Calbiochem (San Diego, CA) and
[3H]ryanodine from Amersham (Piscataway, NJ). Antibodies against the RyR
were obtained from the following sources: RyR1: XA 7B6, Upstate
Biotechnology (Charlottesville, VA); RyR2: Clone C3-33 from RBI/Sigma
(St. Louis, MO); RyR1-3: RyR N19 from Santa Cruz (Santa Cruz CA), RyR3: a
generous gift from Dr. Gerhard Meissner, University of North Carolina.
Antibodies against VDAC and the sarco- and endoplasmic reticulum ATPase
(SERCA) were obtained from Calbiochem (San Diego, CA), and Santa Cruz
(Santa Cruz, CA), respectively. Protease inhibitor Complete was purchased
from Roche Applied Science (Indianapolis, IN). All other chemicals were
purchased from Sigma unless noted otherwise.
2.2. Methods
All procedures for animal use were in strict accordance with the NIH Guide
for the Care and Use of Laboratory Animals, and were approved by the
University Committee on Animal Resources.
2.2.1. RT-PCR
For RT-PCR, the total RNA of 1 rat heart or acutely dissociated single
cardiomyocytes from 1 rat heart was extracted using the RNeasy Mini Kit from
Qiagen. For subsequent cDNA synthesis the Superscripti one-step RT-PCR
with Platinum Taq (Invitrogen, Carlsbad, CA) was used. RT-PCR was
performed according to the instructions given by the supplier. The primers
summarized in Table 1 were used to specifically amplify RNA for RyR1, RyR2,
and RyR3.2.2.2. Isolation of rat heart mitochondria and SR microsomes
Mitochondria were isolated in ice-cold mannitol/sucrose-buffer (M/S
buffer; containing in mM: 225 mannitol, 10 sucrose, 0.5 EGTA, 10 HEPES,
pH 7.4) by differential centrifugation at 500 and 12,000 g, followed by a
purification on a Percoll gradient as described earlier [12,17].
The post-mitochondrial supernatant, obtained after the first centrifugation at
12,000 g, which contains beside cytosolic components SR (heart) and ER
(brain) microsomes, was used to enrich RyR-containing microsomes by
centrifugation for 60 min at 150,000g. The resulting sediment containing
RyR-microsomes was resuspended in a small volume of M/S buffer
supplemented with protease inhibitor. Note that this post-mitochondrial
supernatant was obtained after gentle disrupting the cell membranes of cardiac
or brain tissue with a Teflon-coated potter. As a consequence, the quantity of
RyR-containing microsomes, specifically from cardiac SR is relatively low (see
Fig. 1B, RyR2 lane b) compared to highly optimized protocols published
recently [13,18]. Preparations using the latter protocols result normally in much
stronger signals for RyR2 protein (data not shown).
2.2.3. Preparation of mitochondrial subfractions
IMM vesicles were prepared from isolated rat heart mitochondria by
sucrose-density centrifugation as described previously [12,19]. For all
experiments described here, only such IMM preparations that exhibited a high
succinate dehydrogenase activity (an enzyme, which is found only in the IMM),
but tested negative for SERCA and VDAC (indicative for proteins of the SR
and the outer mitochondrial membrane, respectively) were used (Fig. 1B
SERCA and Fig. 1D).
2.2.4. Isolation of heart mitochondria from neonatal mice
Dyspedic RyR1 knockout mice contain 2 disrupted alleles for RyR1
resulting in a lethal birth defect [20,21]. These mice die immediately after
they are born. For this reason, the tissue homogenates or mitochondria from
RyR1 knockout mice were obtained immediately after these mice were
born. In addition, all experiments were repeated with age-matched surviving
control mice, which were either +/+ or +/ for RyR1, to compensate for
possible developmental differences between the neonatal mice and adult
animals.
The hearts from 2 to 6 newborn RyR1 knockout mice or phenotypically
normal littermate were homogenized in 0.5 ml M/S buffer supplemented with
protease inhibitor. After centrifugation for 10 min at 500g in a tabletop
centrifuge at 4 -C to remove blood cells, plasma membrane fragments and
nuclei, the supernatant was centrifuged for 5 min at 15,000g . The
mitochondria containing sediment was resuspended in M/S-buffer, centrifuged
again for 5 min at 15,000g, and then resuspended in 20–40 Al M/S buffer. A
sample of isolated heart mitochondria from one RyR1 knockout mouse yields
on average in 18T3 Ag protein (n75).
2.2.5. Skeletal muscle microsomes
Skeletal muscle microsomes were obtained from mostly white muscle of
the hind legs of 2 rats according to a modified protocol published recently
[18]. Connective tissue and red appearing muscle tissue were removed by
Fig. 1. RT-PCR and Western blot analysis of RyR1, RyR2, and RyR3 in rat and mouse hearts. (A) RT-PCR of total RNA from 1 rat heart (left) and acutely dissociated
single cardiomyocytes (right) from 1 rat heart demonstrate the message for all 3 RyR subtypes. (B) Western blot analysis with RyR subtype-specific antibodies. Per
lane 60 Ag of protein was used. Probes in lanes a–e are obtained from adult rats while probes in lane f were from adult mice and RyR1 knockout mice (g–h). To
minimize variations due to different preparations and antibodies used at different dates of experiments, all blots in B were done concurrently. Moreover, all blots in
lanes a– f were done with aliquots from the same preparation isolated either from skeletal muscles, heart, or brain. Finally, the samples used for blotting in lanes b, d,
and e were all obtained from the same hearts. a: Skeletal muscle SR, b: cardiac SR microsomes, c: ER containing cytosol from brain, d: heart mitochondria, e: IMM
from heart mitochondria, f: mitochondria from adult mouse, g and h: mitochondria from RyR1 knockout mice. SERCA: Isolated mitochondria from rat heart or the
IMM fractions are free of detectable amounts of SERCA. Note that the detection of SERCA begins in lane b (cardiac SR microsomes). The here used antibody will
detect SERCA protein in the heart or the skeletal muscle but not in the brain. (C) RyR1 protein is detected in heart mitochondria from adult (lanes a1 and a2) and
neonatal control mice (lane b1 and lane f2), but not in neonatal RyR1 knockout mice (lane c1 and the lanes b2–e2). Per lane, 60 Ag of protein was used. Mitochondrial
samples from neonatal control mice contained hearts from both homozygous and heterozygous normal mice. (D) IMM preparations from rat heart mitochondria are
virtually free of VDAC. The samples in lanes a–e were obtained from the same hearts as those samples used for the lanes b, d and e in Fig. 1B. a: cardiac SR
microsomes (50 Ag protein), b: heart mitochondria (20 Ag protein), c: outer mitochondrial membrane (20 Ag protein), d: contacts between outer and inner
mitochondrial membrane (50 Ag protein), e: IMM (50 Ag protein), f – i: IMM fractions from 4 different preparations (50 Ag protein).
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tissue was minced in ice-cold isolation buffer (300 mM sucrose, 5 mM
imidazol pH 7.4, protease inhibitor cocktail Complete) and then homoge-
nized (2 times for 30 s at half-maximal speed) with a Polytron
homogenizer. The homogenate was centrifuged for 10 min at 500g. The
supernatant was stored on ice and the sediment was homogenized and
centrifuged again as before. Skeletal muscle microsomes were obtained from
both supernatants by centrifugation at 30,000g for 20 min.
For [3H]ryanodine binding experiments the sediment was resuspended in
a small volume of isolation buffer. For Western blots, the RyR-containing
microsomes were further purified on a discontinuous sucrose gradient (45,
38, 32, and 27% sucrose) and centrifuged for at least 14 h at 72,000g
[18]. The strongest RyR-signal was obtained from the fractions at the
interface between 32/38 and 38/45% sucrose. These fractions were collected,
diluted with isolation buffer and centrifuged for 90 min at 100,000g in a
Ti60 rotor. The sediment was resuspended in a small volume of isolation
buffer.
2.2.6. Denaturing SDS gel electrophoresis
For the immunological detection of the RyR and SERCA, 60 Ag protein
was loaded on a 5% SDS-page. To transfer RyR or SERCA protein, the
separated proteins were transferred onto a nitrocellulose membrane for 18 h at
35 V or 25 V, respectively. For the immunological detection of VDAC, 20–
50 Ag protein was loaded onto a 12% SDS page and transferred for 50 min at
90 V onto a nitrocellulose membrane. For some experiments, pre-made
gradient gels from Biorad (4–15% acrylamide/bisacrylamide for proteinsbigger than 60 kDa and 10 to 20% acrylamide/bisacrylamide for proteins
smaller than 60 kDa) were used. Western blots were performed using the
ECL kit (Amersham, Piscataway, NJ) with a horseradish peroxidase-
conjugated secondary antibody. Equal protein loading and protein transfer
was ensured by the intensity of the Ponceau Red staining of the nitrocellulose
membrane (not shown).
To obtain sufficient amounts of protein for the immunological detection of
RyR protein from neonatal samples, isolated mitochondria from several
preparations were pooled. To simplify analysis, each of these pooled samples
was counted as one preparation.
2.2.7. [3H]ryanodine binding
For binding assays, 100 Ag mitochondrial proteins were incubated with
different concentrations of [3H]ryanodine in 0.5 ml binding buffer (in mM:
170 KCl, 10 MOPS, pH 7.0) and the indicated Ca2+ concentration for 16
h at 25 -C as described before [12]. For the determination of non-specific
binding, because ryanodine only binds to the open state of RyR, 6 mM
EGTA was added to the Ca2+-free binding buffer to lock RyR in the close
state completely. Calcium standard solutions were prepared with 1 mM
EGTA in ryanodine binding buffer by adding appropriate amounts of a 100
mM CaCl2 solution. The free Ca
2+ concentration was then determined
according to [22]. At the end of the incubation time, the reaction mixture
was filtered under reduced pressure through glass fiber filters (Whatman
GF/B, Maidstone, UK) and washed with ice-cold buffer three times. The
radioactivity in the dried membranes was counted with a liquid scintillation
counter using a toluene-based scintillator.
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O2 consumption of isolated mitochondria from rat hearts (1 mg protein) or
cardiac tissue homogenates obtained from neonatal mouse hearts (0.3 mg
protein) was measured with a Clark-electrode (Hansatech, Norfolk, UK).
Samples were either directly diluted in M/S buffer supplemented with 0.01 mM
EGTA (to chelate Ca2+ impurities in the water), 1 mM Mg2+ and 5 mM
potassium phosphate or after the incubation with 20 AM ryanodine. Incubation
with 20 AM ryanodine (15 min at room temperature) was done in M/S buffer
before the addition of EGTA, Mg2+ and potassium phosphate to ensure high
affinity ryanodine binding. Oxidative phosphorylation was stimulated with 10
AM Ca2+ in the presence of 5 mM malate and 5 mM glutamate as substrate.
While Ca2+ can uncouple oxidative phosphorylation, low concentrations of this
cation have been reported to specifically stimulate the Ca2+-regulated
dehydrogenases of the TCA cycle [23]. The respiratory control index (RCI
[24]) indicates the ability of isolated mitochondria to use ADP for ATP
generation in the presence of a substrate. To calculate the RCI, defined as the
ratio of maximal respiration over substrate-induced respiration, the measured
maximal O2 consumption in presence of 1 mM ADP was divided by the
substrate-mediated O2 consumption (i.e., in the presence of 5 mM succinate or
5 mM malate and 5 mM glutamate).
2.2.9. Measurements of mitochondrial Ca2+ influx with Fura-FF
Isolated heart mitochondria from adult rats were diluted in modified M/S
buffer (in mM: 120 KCl, 65 mannitol, 30 sucrose, 10 succinate, 5 Na2HPO4/
NaH2PO4, 10 HEPES, pH 7.2) to a final protein concentration of approximately
5 mg/ml. Mitochondria were then loaded with the low affinity Ca2+ indicator
Fura-FF (5 AM) in the presence of 0.02% pluronic acid (Gibco, Carlsbad, CA)
for 15 min at room temperature. After washing the mitochondria 3 times with
M/S buffer, supplemented with 10 AM EGTA, mitochondria were kept for 15
min at room temperature to allow complete de-esteration of the fluorescence
dye. The changes of mitochondrial Ca2+ net uptake were monitored with a
Perkin-Elmer LS-5 fluorescence spectrophotometer. The excitation wavelength
was 380 nm and the emission wavelength was 510 nm. Under these
experimental conditions, Ca2+ influx causes a decrease in the fluorescence
( F) signal, which was normalized to the baseline fluorescence ( Fo). Results are
expressed as Fo/F, so that values greater than 1 reflect an increased Ca
2+ net
influx into the mitochondria.3. Results
3.1. RT-PCR indicates the presence of mRNA for all 3 RyR
subtypes in muscle cells from rat heart
Three different RyR isoforms (RyR1, RyR2, and RyR3)
have been cloned and are pharmacologically described (for
reviews see [25,26]). Although the expression of the RyR
subtypes is somewhat tissue specific, with RyR1 being the
major isoform in skeletal muscle, RyR2 in cardiac and
smooth muscle, and RyR3 in the brain, several tissues express
more than one RyR subtype. For example, RyR1 and RyR3
are expressed in the diaphragm, and during early develop-
mental stages both are expressed throughout the skeletal
muscle [27]. RT-PCR with RNA extracts from total rat heart
tissue and purified individual rat adult cardiomyocytes shows
the message of all three RyR-subtypes (Fig. 1A). The
strongest signal was obtained for RyR2, and much weaker
signals were obtained for RyR1 and RyR3 (n=3). The signals
for RyR1 and RyR3 do not arise from fibroblasts, smooth
muscle and/or connective tissue present in these preparations
since similar results were observed for isolated cardiomyo-
cytes further purified by a Percoll density gradient, to remove
non-cardiac cells (Fig. 1A, purified cardiomyocytes; [28]).These data are consistent with recent publications that
indicate the presence of mRNA for all 3 RyR subtypes in
human heart and vascular muscle cells [29–31].
3.2. Subtype-specific antibodies detect RyR1 in mitochondria
isolated from rat and mouse hearts
RT-PCR does not provide information regarding the
subcellular location of the three RyR subtypes. Therefore,
we used specific antibodies to determine the RyR subtype in
SR, intact mitochondria, purified IMM from rat hearts, and
isolated heart mitochondria from adult and neonatal mice.
Fig. 1B shows representative blots obtained from a
concurrent experiment using 4 different RyR antibodies.
With an antibody that detects all three RyR subtypes
(RyR1–3), we found RyR protein in the SR or the ER
enriched microsomes from rat skeletal muscle, heart, and
brain (Fig. 1B, RyR1–3, lanes a, b, and c, respectively;
n =8). This antibody also detected RyR protein in mito-
chondria and IMM preparations isolated from rat hearts (Fig.
1B, RyR1–3, lanes d and e; n =13). The signal in the IMM
was stronger relative to that obtained from isolated
mitochondria because the RyR protein in purified IMM
preparations becomes concentrated without the presence of
proteins from the outer mitochondrial membrane and the
matrix. Mitochondria isolated from adult mouse hearts also
tested positive for RyR protein (Fig. 1B, RyR1–3, lane f;
n =5), and no RyR protein was detected in mitochondria
from neonatal homozygous RyR1 knockout mice (Fig. 1B,
RyR1–3, lanes g and h; n =5).
As expected, the RyR1-specific antibody, XA 7B6 [32,33],
readily detected RyR1 in SR-microsomes from skeletal muscle
(Fig. 1B, RyR1, lane a; n=5). Interestingly, this antibody also
detected RyR protein in mitochondria and IMM vesicles from
rat hearts (Fig. 1B, RyR1, lanes d and e; n =5). A RyR1-
specific signal was also obtained in heart mitochondria from
adult mice (Fig. 1B, RyR1, lane f, Fig. 1C, lanes a1 and a2;
n =5) and neonatal control mice (Fig. 1C, lane b1 and lane f2;
n =3), but not from RyR1 knockout mice (Fig. 1B, RyR1, lane
g and h, Fig. 1C, lane c1 and the lanes b2–e2; n =5). These data
indicate that the RyR1 gene encodes the cardiac mRyR and that
the lack of detection of RyR1 protein in cardiac mitochondria
from RyR1 knockout mice does not arise from the early
developmental state.
The monoclonal antibody C3–33 detects RyR2 with high
affinity, but has only a very weak affinity for RyR1 [34]. As
expected, cardiac SR-containing microsomes tested positive for
RyR2 protein using this antibody (Fig. 1B, RyR2, lane b;
n =5). However, we obtained no RyR2-specific signal with this
antibody in any mitochondrial sample obtained from adult rats,
adult mice, or neonatal control or RyR1 knockout mice (Fig.
1B, RyR2, lanes d–h; n15). The absence of RyR2-specific
immunoreactivity in all cardiac mitochondrial preparations
provides strong evidence that RyR2-containing SR fragments
do not contaminate the purified mitochondrial preparations.
Similarly, the mitochondrial samples also lacked immunoreac-
tivity to a RyR3-specific antibody (Fig. 1B, RyR3, lanes d–h)
Fig. 3. Ryanodine and dantrolene inhibit mitochondrial Ca2+ uptake. Fura-FF-
loaded isolated heart mitochondria from rat were challenged with 10 or 50 AM
Ca2+ and mitochondrial Ca2+ uptake was measured (white columns).
Preincubating mitochondria for 15 min with 10 AM dantrolene (black columns)
or 20 AM ryanodine (gray columns) inhibited Ca2+ uptake. The excitation
wavelength was 380 nm and the emission wavelength was 510 nm. Under these
experimental conditions, mitochondrial Ca2+ uptake causes a decrease in the
fluorescence ( F) signal, which was normalized to the baseline fluorescence
( Fo) at the begin of the experiment. Results are expressed as [ Fo/F], so that the
ratio before the addition of Ca2+ is 1 and mitochondrial Ca2+ net uptake is
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skeletal muscle and brain cytosol, respectively (n =4).
In summary, our results obtained by Western blotting with
subtype-specific RyR antibodies and the use of RyR1 knockout
mice strongly indicate that RyR1 corresponds to the mRyR
(heretofore termed as mRyR1) and that mRyR1 is the only
RyR-subtype in heart mitochondria. This result is supported by
genetic analysis which do not provide evidence for additional
RyR subtypes besides the 3 known subtypes [35,36].
3.3. Pharmacological characterization of mRyR1 by
ryanodine, caffeine, and AMPPCP
Because ryanodine preferentially binds to the open state of
the RyR, the binding of [3H]ryanodine is widely used as an
indicator of RyR activation by a variety of modulatory factors
(for review, see [26]). [3H]ryanodine binds in a prototypical
bell-shaped Ca2+ dependence to isolated heart mitochondria.
Maximal [3H]ryanodine binding to isolated mitochondriaFig. 2. Modulation of [3H]ryanodine binding to isolated rat heart mitochondria
by ryanodine caffeine, and AMPPCP. (A) Ca2+ dependency of [3H]ryanodine
binding to isolated heart mitochondria (&), cardiac SR (o) and skeletal muscle
SR microsomes (g). (B) Ca2+ dependency of [3H]ryanodine binding to isolated
rat heart mitochondria in absence (&) or presence (o) of 10 mM caffeine. (C)
AMPPCP increases [3H]ryanodine binding. Mitochondria were incubated in the
absence (white column) or presence (black column) of 2 mM AMPPCP and the
indicated concentration of [3H]ryanodine. For both experiments, the binding of
[3H]ryanodine in absence of AMPPCP was set to be 100%; data represent the
mean of 3 experimentsTS.E. Asterisks (*) indicate statistical significance
( P0.05).
reflected as an increase of the ratio. Data represent the average of 4
experimentsTS.E., and asterisks (*) indicate statistical significance ( P <0.01).occurs at ¨pCa of 4.4 and is completely blocked at pCa 2
(Fig. 2A, close circles; n=3; see also [12]). To substantiate the
data obtained by Western blot analysis showing that mRyR is
RyR1, we compared [3H]ryanodine binding to mitochondria
with that to cardiac and skeletal muscle SR microsomes. We
found that [3H]ryanodine binding to cardiac microsomes peaks
at pCa 3 and is less sensitive to the inhibition by higher
concentrations of Ca2+ (Fig. 2A, open circles; n =3). Consistent
with the results obtained by Western blotting, Ca2+-dependent
[3H]ryanodine binding to skeletal muscle microsomes is bell-
shaped as observed for the binding to isolated mitochondria
(Fig. 2A, open rectangles). Both the lower sensitivity of RyR2
to Ca2+-dependent inactivation of [3H]ryanodine binding and
the bell-shaped binding curve to skeletal muscle microsomes
(Fig. 2A) are consistent with the published literature [37]. The
maximal [3H]ryanodine binding to cardiac and skeletal muscle
microsomes (per mg protein) was several times higher than that
of heart mitochondria, indicating considerably fewer ryanodine
binding sites in mitochondria, while the Kd’s are virtually
identical [12,38].
Caffeine is known to increase [3H]ryanodine binding to the
skeletal and cardiac SR-RyR in a distinct pattern [15]. Using
isolated heart mitochondria maximal [3H]ryanodine binding
increased about 30% in the presence of 10 mM caffeine at pCa
4–5 (Fig. 2B, 3–6 experiments per Ca2+ concentration;
P0.05). This observed increase in [3H]ryanodine binding
to isolated heart mitochondria by caffeine is quantitatively
similar to that described for RyR1 in the skeletal muscle and is
significantly less than that observed for cardiac RyR2, where
caffeine causes a much more pronounced increase of [3H]rya-
nodine binding [15].
The non-hydrolysable ATP-analogue AMPPCP increases
Ca2+-stimulated [3H]ryanodine binding to RyR1, but not
RyR2 [15,39]. Therefore, heart mitochondria were incubated
in the presence of 2 mM AMPPCP and 20 AM Ca2+ with 3
Fig. 4. Ca2+ stimulated O2 consumption in isolated heart mitochondria in the
presence of different concentrations of Mg2+. The experimental conditions are
described in Methods. Although 1 mM Mg2+ lowers the response to Ca2+
stimulated O2 consumption, the stimulating effect of Ca
2+ still remains
significant ( P0.006).
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increased [3H]ryanodine binding to isolated mitochondria
up to 61T5.2% (Fig. 2C; n =5), and maximal [3H]ryanodine
binding in the absence of AMPPCP was set to be 100%.
This effect of AMPPCP-increased [3H]ryanodine binding is
consistent with the behavior of RyR1.
3.4. Ryanodine inhibits Ca2+ stimulated oxygen consumption
An increase in the mitochondrial matrix Ca2+ concentration
activates the pyruvate-, isocitrate-, and a-ketoglutarate dehy-
drogenase in the TCA cycle to generate NADH and FADH [4].
The complexes of the electron transport chain then use these
substrates for mitochondrial ATP generation by oxidative
phosphorylation. To test the role of Ca2+ influx via mRyR1
on modulating oxidative phosphorylation, it is essential to
expose mitochondria to Ca2+ concentrations that preferentially
stimulate mRyR1 but not CaUP. Therefore, mitochondrial Ca2+
net uptake and the inhibition by ryanodine and dantrolene were
directly monitored with the low affinity Ca2+ indicator Fura-FF
(Fig. 3). The Fura-FF signal, expressed as Fo/F, increased from
1 (baseline) to 1.6T0.04 (n =4; P0.01) when extramitochon-
drial Ca2+ concentration was raised to 10 AM. This increase
was significantly abolished after pre-incubating mitochondria
with ryanodine or dantrolene (1.08T0.017 and 1.14T0.093,
respectively; n =4). The net uptake of Ca2+ at a higher
concentration of extramitochondrial Ca2+ (50 AM) was
inhibited less effectively by ryanodine and dantrolene (Fig.Table 2
Ca2+ stimulated O2 consumption of isolated mitochondria from rat heart and the ti
0 AM ryanodine
Substr. Substr.+Ca2+
Adult rat (n =5) 43.48T7.09 60.51T5.59
Neonatal control mice (n =5) 26.97T3.53 35.37T3.13
Neonatal RyR1 / mice (n =5) 36.28T5.53 35.6T8.41
Substr.: oxidative activity in presence of 5 mM malate and 5 mM glutamate. Substr
index; defined in this experiment as the ratio of maximal respiration in presence of 5
and glutamate) respiration. After pre-incubation with 20 AM ryanodine, Ca2+ stimula
(except for the RCI)TS.E. and * indicates statistical significance ( P0.05).3), likely due to the activation of other Ca2+ uptake mechan-
isms such as the CaUP. Therefore, we used 10 AM Ca2+ to
stimulate oxidative phosphorylation.
We measured O2 consumption in isolated heart mitochon-
dria in the presence of Mg2+, because it improved the state 2
respiration significantly in our experiments. However, Mg2+ is
known to close the Ca2+ channel in the ryanodine receptor [26]
and the CaUP [8]. To account for this inhibitory effect of Mg2+,
we determined O2 consumption in the presence of 0, 0.5, 1, and
5 mM Mg2+. Oxygen consumption in the presence of 1 mM
Mg2+ was only slightly less compared to 0 or 0.5 mM Mg2+
(Fig. 4; n =4). In the presence of 5 mM Mg2+, O2 consumption
was significantly inhibited.
State 2 respiration in the presence of malate and glutamate
was 43.5T7.1 nmol O2/min/mg mitochondrial protein and
increased to 60.5T5.6 nmol O2/min/mg protein after the
addition of 10 AM Ca2+ (Table 2; n =5; P0.05). However,
after pre-incubating isolated heart mitochondria with 20 AM
ryanodine, 10 AM Ca2+ was not longer effective to stimulate O2
consumption (50T6.4 nmol/O2/min/mg protein compared to
48.8T4.8 nmol O2/min/mg before the addition of Ca
2+; n =5).
Ryanodine itself did not cause the inhibitory effect by
interfering with the mitochondrial functionality, because the
RCI, an indicator of mitochondrial function, did not change
(4.5T1.1 and 4.5T0.8, for control and ryanodine-treated
mitochondria, respectively; Table 2; n =5). To account for a
possible contamination of the mitochondria by Ca2+ filled SR
vesicles we performed this experiment in the presence of
cyclopiazonic acid to empty these vesicles and to inhibit Ca2+
uptake into SR vesicles by SERCA. However, the presence of
30 AM cyclopiazonic acid did not change Ca2+ stimulated O2
consumption either in the presence or absence of ryanodine
(data not shown).
Addition of 10 AM Ca2+ also increased O2 consumption
in heart homogenates of neonatal control mice from
27.0T3.5 nmol O2/min/mg (n =5) to 35.4T3.1 nmol O2/
min/mg (Table 2; n =4; P0.05). Similar to isolated heart
mitochondria from adult rats, pre-incubation of heart
homogenates from neonatal control mice with 20 AM
ryanodine abolished Ca2+-stimulated oxidative activity
(28.0T3.5 nmol O2/min/mg and 27.2T1.5 nmol/O2/min/mg
before and after the addition of Ca2+, respectively; n =4).
Again, the presence of cyclopiazonic acid had no effect on
Ca2+ stimulated oxidative phosphorylation in neonatal
control mice (data not shown).ssue homogenate from neonatal control mouse hearts
20 AM ryanodine
RCI Substr. Substr.+Ca2+ RCI
4.5T1.09 48.77T4.84 50.04T6.38 4.5T0.82
2.47T0.2 28.02T3.53 27.2T1.49 2.4T0.31
1.12T0.2
+Ca2+: increase of oxidative activity by 10 AM Ca2+. RCI: respiratory control
mM malate and 5 mM glutamate and 1 mM ADP over substrate-induced (malate
ted oxidative activity was inhibited. Values are given as nmol O2/min/mg protein
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knockout mice, addition of 10 AM Ca2+ did not further
stimulate mitochondrial oxidative activity, because the sub-
strates malate and glutamate itself caused already maximal O2
consumption (36.3T5.5 nmol O2/min/mg and 35.6T8.4 nmol
O2/min/mg in the absence and presence of 10 AM Ca2+,
respectively; n =5). In these experiments, the addition of Ca2+,
ADP, the uncoupler dinitrophenol, or atractyloside, an inhibitor
of the adenine nucleotide translocator, did not change the rate
of O2 consumption. However, the very low RCI of RyR1
knockout mice (1.12T0.04 compared to 2.47T0.2 of control
mice) indicates that the expression of mRyR1 appears to be
essential for the normal respiration of cardiac mitochondria
(Table 2).
4. Discussion
The specific aims of this study were to identify the subtype
of RyR in mitochondria and to show that Ca2+ via mRyR is a
critical component for mitochondrial energy production.
4.1. Characterization of the mRyR as RyR1
The data presented here demonstrate that the RyR in cardiac
mitochondria exhibits biochemical, pharmacological, and
functional properties, remarkably similar to those of RyR1 in
the SR of skeletal muscle, and is therefore termed as mRyR1.
We used isolated mitochondria from four different resources:
adult rats, adult mice, newborn control and newborn RyR1
knockout mice. Dyspedic RyR1 knockout mice contain 2
disrupted alleles for RyR1 resulting in a lethal birth defect
[20,21]. To compensate for possible developmental differences
between the newborn mice and adult animals, all experiments
were repeated with newborn surviving control mice, which
were either homozygous (+/+) or heterozygous (+/) for
RyR1. Even though RyR1 knockout mice have no functional
RyR1 in the SR, many ultrastructural details of the triadic
junctions are still detectable in these mice [20]. However,
important differences are that dyspedic muscles lack the
regularly spaced array of junctional feet that span the gap
between the T-tubule and SR membranes and they also lack the
tetradic arrangement of dihydropyridine receptors.
In our experiments, the subtype specific antibody XA7B6
detects RyR1 protein in mitochondria from adult rat or
mouse hearts (Fig. 1B). The specificity of this antibody is
confirmed by the presence of a RyR1 signal in the skeletal
muscle SR but not in the cardiac SR or mitochondria
obtained from RyR1 knockout mice (Fig. 1B). In addition,
the presence of RyR1 protein in neonatal control mice,
which are either homozygous or heterozygous for RyR1,
minimizes the possibility that the absence of RyR1 protein
in RyR1 knockout mice is due to the developmental stage of
the mice. The less pronounced RyR1 signal in newborn
mice compared to adult mice can be explained by a lower
expression at this early age or the possibility that the
majority of the control mice were heterozygous for RyR1.
The signal for RyR1 protein obtained from IMM vesicles isstronger than that from isolated mitochondria, indicating a
higher concentration of RyR1 protein in the IMM compared
to the intact mitochondria. Although we obtained the mRNA
message for RyR3 in heart tissue and isolated cardiomyo-
cytes, we could not detect RyR3 protein in the tested
cardiac subfractions (Fig. 1B). It is likely that the expression
level of RyR3 is very low and thus beyond the detection
limit of Western blot analysis.
Even though genetic analysis provides no evidence for
additional RyR-subtypes besides the 3 known subtypes
[35,36], the here presented results cannot exclude the
possibility that mRyR1 is a splice variant of RyR1. Indeed, it
has been shown that the used RyR1 specific antibody XA 7B6
still detects a 172-kDa N-terminal cleavage product of RyR1
[40]. In addition, splice variants of RyR2 and RyR3 have been
identified [41,42].
The pharmacological profile of modulation of [3H]
ryanodine binding to isolated mitochondria by Ca2+,
caffeine, and AMPPCP provides further evidence that mRyR
is RyR1. The Ca2+-dependent binding of [3H]ryanodine to
cardiac mitochondria is biphasic (Fig. 2A) and resembles the
characteristics of [3H]ryanodine binding to RyR1 in the SR
of skeletal muscle [39]. Inhibition of [3H]ryanodine binding
to RyR1 has been described for pCa4 (for review, see
[26]). In contrast, Ca2+ dependent inhibition of [3H]ryano-
dine binding to the cardiac RyR2-subtype requires much
higher concentrations of Ca2+ (Fig. 2A) [39]. Furthermore,
the characteristics of caffeine and AMPPCP modulation
coincide with that of RyR1 not of RyR2 (Fig. 2B and C,
[15,37]). Finally, dantrolene, which inhibits more selectively
the Ca2+ channel of RyR1 [43], blocks mitochondrial Ca2+
net uptake effectively and thus, adds functional evidence
that mRyR is RyR1 (Fig. 3).
4.2. Functional implication of differential location of RyR1 and
RyR2 in cardiac muscle cells
Our data obtained by Western Blot analysis of subcellular
fractions indicate that in the heart RyR2 is localized in the
SR, while RyR1 is localized in mitochondria. One reason
for this differential localization of RyRs in cardiac muscle
cells is that they serve for different functional roles. In
cardiac muscle cells, Ca2+ influx through voltage gated Ca2+
channels activate RyR2 channels, resulting in Ca2+ induced
Ca2+ release from the SR. The Ca2+-dependency of
ryanodine binding implies that a micro-domain of high
Ca2+, near SR–mitochondria junction, does not inactivate
RyR2 significantly during excitation–contraction coupling,
so that a large amount of Ca2+ can be released from the SR
to trigger muscle contraction. On the contrary, the bell-
shaped pCa-dependence of ryanodine binding suggests that
mRyR1 becomes activated as soon as Ca2+ is released from
the SR and will be maximally activated at Ca2+ concentra-
tions of about 10 to 40 AM. Further increases in the local
Ca2+ concentration lead to inactivation of mRyR1 to prevent
mitochondrial Ca2+ overload and opening of permeability
transition pore.
Fig. 5. Simulation of Ca2+ sensitivity of mRyR1 and CaUP. In this graph the
normalized Ca2+ dependent CaUP current (ICaUP, black line) was simulated
according to [10]. The normalized open probability of RyR1 (Po(RyR1), blue
line) was simulated according to [50]. The red line represents our [3H]ryano-
dine binding data (filled squares, red line) from isolated rat heart mitochondria.
The simulation shows that the open probability of RyR1 and the Ca2+
dependency of [3H]ryanodine binding to isolated heart mitochondria appear not
significantly different.
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inhibitory effect on the RyRs [44,45] and one would expect
that Mg2+ inhibits mRyR1 under physiological conditions [46].
However, the concentration of Mg2+ to inhibit RyR2 by 50% is
a few mM, which is approximately 10 times higher than that
for inhibiting RyR1 (¨0.3 mM). Mg2+ inhibits the non-
phosphorylated RyR. In the presence of ATP or other adenineFig. 6. The mRyR1 as a transducer of excitation–metabolism coupling. With each h
around the mitochondria). Hypothetically, mitochondria in close proximity to the S
activate several dehydrogenases associated with the TCA cycle (highlighted in red) a
isocitrate dehydrogenase; KDH, a-ketoglutarate dehydrogenase; MDH malate dehynucleotides, Ca2+ permeability through RyR is increased even
in the presence of physiological concentrations of Mg2+ [38].
In addition, it is possible that the formation of Mg-ATP in the
intermembrane space keeps the free concentration of Mg2+
locally low enough to prevent a complete inhibition of mRyR1.
Furthermore, the presence of Mg-ATP is essential for the
function of a number of mitochondrial kinases or the
mitochondrial KATP-channel.
Functionally, the RyR1 in the skeletal muscle is coupled to
the activity of voltage activated, dihydropyridine-sensitive Ca2+
channels [37]. Opening of this channel via depolarization
transmits the activating signal to RyR1. An interesting hypoth-
esis for mRyR1 is that Ca2+ influx throughVDAC could transmit
the activating signal to mRyR1. It has been shown that VDAC
has the ability to regulate Ca2+ transport across the outer
mitochondrial membrane [47]. The selectivity of VDAC for
cations or anions in bilayer experiments depends on the applied
voltage [48] and could provide in vivo a model how VDAC
channels regulate mRyR1. This mechanism would allow a
regulated Ca2+ flow across the outer mitochondrial membrane as
well as Ca2+ influx into the mitochondrial matrix.
4.3. Simulation of Ca2+ dependency of mRyR1 versus CaUP
Despite the unknown molecular identity, the functional
properties of CaUP are well established (for reviews see
[8,49]). In general, the results show that the relationship
between the initial rates of Ca2+ uptake by CaUP and the extra
mitochondrial Ca2+ concentration is sigmoidal, assuming a Hill
coefficient of 2 and a half maximal transport velocity varyingeart beat Ca2+ is released from the SR into the cytosol (indicated by the red area
R could respond with fast mitochondrial Ca2+ uptake mediated by mRyR1 to
nd subsequent oxidative phosphorylation. PDH, pyruvate dehydrogenase; IDH,
drogenase; ETC electron transport chain.
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mitochondrial Ca2+ uptake by the CaUP has been challenged
recently by a study using patch-clamp to record CaUP currents
in mitoplasts isolated from COS-7 cell [10]. In these experi-
ments, half-maximal saturation of the CaUP was achieved at
approximately 20 mM Ca2+ and reached saturation at 105 mM
[10]. Plotting the normalized currents of CaUP and RyR1 as a
function of Ca2+ concentration using the assumptions discussed
in [10] and [50], respectively, shows that the open probability
of RyR1 peaks in the presence of 10–30 AM Ca2+ (Fig. 5, blue
trace), while the CaUP is fully activated at much higher
concentrations of Ca2+ (Fig. 5, black trace). Our data of
[3H]ryanodine binding to isolated mitochondria at different
concentration of Ca2+ indicate that mRyR1 becomes activated
at low concentrations of Ca2+ and inactivated by higher Ca2+
concentration like RyR1 (Fig. 5, red trace). This analysis
suggests that the CaUP with its low affinity and high capacity
for mitochondrial Ca2+ uptake is better suited for reducing a
possible cytosolic Ca2+ overload to prevent necrotic or
apoptotic cell death [8].
4.4. Ca2+ stimulated O2 consumption is inhibited by ryanodine
Our experiments show that Ca2+ uptake via mRyR1
stimulates O2 consumption when the extramitochondrial Ca
2+
concentration was raised to 10 AM. This process is inhibited by
ryanodine. Interestingly, at 50 AM extra-mitochondrial Ca2+
concentration, the inhibitory effects by ryanodine or dantrolene
became smaller. It is likely that the mitochondrial CaUP
becomes activated at this concentration of Ca2+, consistent with
the simulated Ca2+ dependencies shown in Fig. 5. Ca2+
stimulated O2 consumption was not measurable in tissue
homogenates from RyR1 knockout mice, because the addition
of substrates alone increased already O2 consumption to a level
not distinguishable from maximal respiration induced by the
addition of dinitrophenol. The rate of O2 consumption did also
not change upon the addition of ADP (to stimulate maximal
respiration) or atractyloside, an inhibitor of the adenine
nucleotide translocase, indicating the loss of mitochondrial
function in RyR1 knockout mice.
The close proximity between SR and mitochondria allows
the formation of discrete micro-domains with high Ca2+
concentration, sufficient to activate rapid mitochondrial Ca2+
uptake mechanisms [51,52]. However, the low affinity of the
CaUP for Ca2+ (Kd50 AM) and the velocity of Ca2+ uptake
[8] make this Ca2+ channel a poor candidate to regulate Ca2+-
induced ATP generation on a beat-to-beat basis. In contrast, the
Km of the high affinity binding site of RyR1/mRyR1 for Ca
2+
activation is about 1AM [14,53], and sufficient to connect
cardiac excitation–contraction coupling with mitochondrial
energy metabolism during physiological Ca2+ oscillations.
Together, these results would support a concept of ‘‘excita-
tion–metabolism coupling’’ (Fig. 6). In this scheme, cytosolic
Ca2+ oscillations during heartbeats could trigger mitochondrial
Ca2+ uptake via the mRyR1 and subsequently activate Ca2+
regulated dehydrogenases in the TCA cycle. NADH and
FADH, the products of the TCA cycle, would then increaseATP generation by entering the electron transport chain and
stimulation of oxidative phosphorylation.
In conclusion, mRyR1 may function as a transducer of
myoplasmic Ca2+ signals into the mitochondria to regulate
energy generation. Since cellular Ca2+ homeostasis, ATP
generation, and reactive oxygen species production are crucial
in maintaining life, dysfunction of mRyR may be critical in the
etiology of diseases such as skeletal and cardiac myopathy,
ischemia–reperfusion injury, central core disease and neuro-
degenerative diseases [54].
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